Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Increased Mac 2-Binding Protein Glycan Isomer (M2BPGi) Would Predict Late Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation

Yu Akahoshi, MD, Hideki Nakasone, MD PhD, Koji Kawamura, MD PhD, Miki Sato, MD PhD, Misato Kikuchi, MD PhD, Yukiko Misaki, MD, Kazuki Yoshimura, MD, Ayumi Gomyo, MD, Aki Tanihara, Masaharu Tamaki, MD, Machiko Kusuda, MD, Hidenori Wada, MD, Shun-Ichi Kimura, MD PhD, Shinichi Kako, MD, Yoshinobu Kanda, MD PhD

Blood (2018) 132 (Supplement 1): 2125.

https://doi.org/10.1182/blood-2018-99-113974

Published: 2018

Journal Articles

The Expression of CD83 Would be Increased in CD34-Positive Monocytes Detected in Peripheral Blood Mobilized By G-CSF in Humans

Hideki Nakasone, MD PhD, Misato Kikuchi, MD PhD, Yu Akahoshi, MD, Koji Kawamura, MD PhD, Miki Sato, MD PhD, Kazuki Yoshimura, MD, Yukiko Misaki, MD, Ayumi Gomyo, MD, Aki Tanihara, Machiko Kusuda, MD, Masaharu Tamaki, MD, Shun-Ichi Kimura, MD PhD, Shinichi Kako, MD, Yoshinobu Kanda, MD PhD

Blood (2018) 132 (Supplement 1): 2063.

https://doi.org/10.1182/blood-2018-99-112084

Published: 2018

Journal Articles

Impact of Pretransplant HTLV-1 Seropositivity on Hematopoietic Stem Cell Transplantation for the Diseases Other Than ATLL- an Analysis on Behalf of JSHCT Complication Working Group-

Nobuaki Nakano, MD, Hideki Nakasone, MD PhD, Shigeo Fuji, MD PhD, Akihito Shinohara, MD PhD, Ritsuro Suzuki, MD PhD, Atae Utsunomiya, MD PhD, Tetsuya Eto, MD PhD, Yasushi Sawayama, MD, PhD, Sawako Nakachi, MD PhD, Naoyuki Uchida, MD PhD, Takahiro Fukuda, MD PhD, Junya Kanda, MD, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD

Blood (2018) 132 (Supplement 1): 4641.

https://doi.org/10.1182/blood-2018-99-114111

Published: 2018

Journal Articles

Would Bone Marrow be Associated with Superior Outcomes Compared with Peripheral Blood for Male Recipients with Female Donors in HLA-Matched Related Transplantation?

Hideki Nakasone, MD PhD, Koji Kawamura, MD PhD, Kimikazu Yakushijin, MD, Akihito Shinohara, MD PhD, Heiwa Kanamori, MD PhD, Kazuteru Ohashi, MD PhD, Takahiro Fukuda, MD PhD, Naoyuki Uchida, MD PhD, Hirohisa Nakamae, Junya Kanda, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Yoshihiro Inamoto, MD PhD, Sachiko Seo, MD PhD, Fumihiko Kimura, Prof, MD PhD, Masao Ogata, MD PhD

Blood (2018) 132 (Supplement 1): 4669.

https://doi.org/10.1182/blood-2018-99-113790

Published: 2018

Journal Articles

Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis

Shinichi Kako, MD, Shin-ichiro Fujiwara, MD PhD, Miki Sato, Shun-ichi Kimura, Hideki Nakasone, MD/PhD, Kazuteru Ohashi, MD FACP, Michihiro Hidaka, MD PhD, Tetsuo Maeda, Morishita Takanobu, MD, Ritsuro Suzuki, MD PhD, Takahiro Fukuda, MD, Tatsuo Ichinohe, MD PhD, Mio Kurata, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2017) 130 (Supplement 1): 3235.

https://doi.org/10.1182/blood.V130.Suppl_1.3235.3235

Published: 2017

Journal Articles

Impact of Total Body Irradiation on Successful Neutrophil Engraftment in Unrelated Bone Marrow or Cord Blood Transplantation

Hideki Nakasone, MD/PhD, Kimikazu Yakushijin, MD PhD, Shigeo Fuji, MD, Makoto Onizuka, MD PhD, Akihito Shinohara, MD PhD, Kazuteru Ohashi, MD FACP, Koichi Miyamura, MD PhD, Naoyuki Uchida, MD PhD, Minoko Takanashi, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Takahiro Fukuda, MD, Masao Ogata

Blood (2016) 128 (22): 3423.

https://doi.org/10.1182/blood.V128.22.3423.3423

Published: 2016

Journal Articles

Targeting Complete Response with Upfront Bortezomib Followed By Autologous Transplantation and Consolidation Therapy for Untreated Multiple Myeloma (TUBA study)

Hideki Nakasone, MD/PhD, Kiriko Terasako-Saito, Teiichi Hirano, MD, Atsushi Wake, MD PhD, Seiichi Shimizu, MD PhD, Etsuko Yamazaki, MD PhD, Kouhei Akazawa, Kensuke Usuki, MD PhD, Shigeru Chiba, MD, PhD, Koichiro Minauchi, MD, Etsuo Miyaoka, Shuichi Ota, MD, Shuichi Taniguchi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2016) 128 (22): 3463.

https://doi.org/10.1182/blood.V128.22.3463.3463

Published: 2016

Journal Articles

Allogeneic HY Antibodies 3 Months Following Sex-Mismatched HCT Predicts Chronic Graft-Versus-Host Disease and Non-Relapse Mortality

Hideki Nakasone, MD, PhD, Lu Tian, Takakazu Kawase, M.D., Bita Sahaf, PhD, Rakesh Popli, Joyce Lee, Kelsi Schoenrock, Spenser Perloff, Fang Wu, Joanne M Otani, RN, MSN, Andrea M. H. Towlerton, Shoko Satoh, Edus H. Warren, III, MD, PhD, David B. Miklos, MD, PhD

Blood (2013) 122 (21): 147.

https://doi.org/10.1182/blood.V122.21.147.147

Published: 2013

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Increased Mac 2-Binding Protein Glycan Isomer (M2BPGi) Would Predict Late Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation

The Expression of CD83 Would be Increased in CD34-Positive Monocytes Detected in Peripheral Blood Mobilized By G-CSF in Humans

Impact of Pretransplant HTLV-1 Seropositivity on Hematopoietic Stem Cell Transplantation for the Diseases Other Than ATLL- an Analysis on Behalf of JSHCT Complication Working Group-

Would Bone Marrow be Associated with Superior Outcomes Compared with Peripheral Blood for Male Recipients with Female Donors in HLA-Matched Related Transplantation?

Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis

Impact of Total Body Irradiation on Successful Neutrophil Engraftment in Unrelated Bone Marrow or Cord Blood Transplantation

Targeting Complete Response with Upfront Bortezomib Followed By Autologous Transplantation and Consolidation Therapy for Untreated Multiple Myeloma (TUBA study)

Allogeneic HY Antibodies 3 Months Following Sex-Mismatched HCT Predicts Chronic Graft-Versus-Host Disease and Non-Relapse Mortality

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only